Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA. [electronic resource]

By:

Nathwani, A C

Contributor(s):

Davidoff, A
Hanawa, H
Zhou, J F
Vanin, E F
Nienhuis, A W

Producer: 20010419Description: 1258-65 p. digitalISSN:

0006-4971

Subject(s):

Animals
Antibodies -- analysis
DNA, Complementary -- pharmacokinetics
DNA, Recombinant
Dependovirus -- genetics
Factor IX -- genetics
Genetic Vectors -- administration & dosage
Humans
Injections, Intramuscular
Injections, Intravenous
Male
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, SCID
Portal Vein
Time Factors
Tissue Distribution
Transduction, Genetic -- methods

Online resources:

Available from publisher's website

In: Blood vol. 97

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

There are no comments on this title.

Browse results Close

Back to results

41 [Thrombocytopenia and thrombocytopathy in neonates and infants].
by Brolíková, D
42 [Platelet alpha2-adrenergic receptors in essential hypertension. Number of binding sites, cyclic adenosine monophosphate and platelet aggregation].
by Prikryl, P
43 [Thrombohaemorrhagic syndrome in patients with a myeloproliferative disease with thrombocythemia].
by Penka, M
44 [Significance of urokinase and its inhibitors in the invasiveness and metastasing of malignant tumors].
by Halámková, J
45 Prophylaxis with recombinant factor VIIa for the management of bleeding episodes during immune tolerance treatment in a boy with severe haemophilia A and high-response inhibitors.
by Blatny, J
46 Efficacy and safety of chronic hepatitis C treatment in hemophilic patients.
by Husa, P
47 [Preparation of patients on anticoagulant treatment for invasive surgery].
by Brejcha, M
48 Hemocoagulation disorders in extensively burned patients: pilot study for scoring of the DIC.
by Lipový, B
49 High Level of Circulating Microparticles in Patients with BCR/ABL Negative Myeloproliferative Neoplasm - a Pilot Study.
by Aswad, M H
50 Herpes simplex infection as possible etiology for febrile neutropenia and mucositis in patients treated for hematological malignancies.
by Kubesová, H
51 Sample processing and methodological pitfalls in multiple myeloma research.
by Potácová, A
52 [Warning signs preceding the development of septic shock in patients with neutropenia treated for hematologic malignancies].
by Kubesová, H
53 [Involvement of the cardiac muscle in anemia].
by Elbl, L
54 Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic.
by Salaj, P
55 [The effectiveness of anagrelide treatment in patients with Ph negative myeloproliferative diseases: influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with other myeloproliferative diseases treated with Thromboreductin® to the end of 2012].
by Penka, M
56 Minimal Residual Disease Assessment in Multiple Myeloma by Multiparametric Flow Cytometry.
by Rihova, L
57 [The preparation of a patient with long-term anticoagulant cumarin treatment for invasive surgery].
by Penka, M
58 Severe postpartum haemorrhage treated with recombinant activated factor VII in 80 Czech patients: analysis of the UniSeven registry.
by Blatný, J
59 Biobanking - the First Step to Successful Liquid Biopsy Experiments.
by Almasi, M
60 Isolation and expansion of allogeneic myeloma-specific interferon-gamma producing T cells for adoptive immunotherapy.
by Ocadlikova, Darina

Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA.

APA

Nathwani A. C., Davidoff A., Hanawa H., Zhou J. F., Vanin E. F. & Nienhuis A. W. (20010419). Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA. : Blood.

Chicago

Nathwani A C, Davidoff A, Hanawa H, Zhou J F, Vanin E F and Nienhuis A W. 20010419. Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA. : Blood.

Harvard

Nathwani A. C., Davidoff A., Hanawa H., Zhou J. F., Vanin E. F. and Nienhuis A. W. (20010419). Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA. : Blood.

MLA

Nathwani A C, Davidoff A, Hanawa H, Zhou J F, Vanin E F and Nienhuis A W. Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA. : Blood. 20010419.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC